title: Blood pressure changes during treatment with recombinant human erythropoietin.
authors.affiliation: Nephrology Division, Klinikum München-Grosshadern, Ludwigs-Maximilians University, München, FRG.
authors.forename: W
authors.initials: W
authors.lastname: Samtleben
authors.forename: C A
authors.initials: CA
authors.lastname: Baldamus
authors.forename: J
authors.initials: J
authors.lastname: Bommer
authors.forename: W
authors.initials: W
authors.lastname: Fassbinder
authors.forename: B
authors.initials: B
authors.lastname: Nonnast-Daniel
authors.forename: H J
authors.initials: HJ
authors.lastname: Gurland
mesh_terms: D000328:Adult; D000740:Anemia / Q000209:etiology / Q000628:therapy*; D001794:Blood Pressure; D002986:Clinical Trials as Topic; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000209:etiology*; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D011994:Recombinant Proteins / Q000627:therapeutic use*
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin